XML 44 R31.htm IDEA: XBRL DOCUMENT v3.21.1
Stockholders' Equity (Tables)
 3 Months Ended
Mar. 31, 2021
Stockholders' Equity Note [Abstract]  
Schedule of Preferred Stock Dividend Declaration and Payment
The following table presents cash dividends declared by the Company on its Series B Preferred Stock from January 1, 2021 through March 31, 2021:

Year Declaration Date Record DatePayment DateDividend Per Share
2021February 19, 2021March 5, 2021March 31, 2021$0.46875
The following table presents cash dividends declared by the Company on its Series C Preferred Stock from January 1, 2021 through March 31, 2021:

Year Declaration Date Record DatePayment DateDividend Per Share
2021February 19, 2021March 5, 2021March 31, 2021$0.40625
(b)  Dividends on Common Stock
 
The following table presents cash dividends declared by the Company on its common stock from January 1, 2021 through March 31, 2021:

Year
Declaration Date
Record DatePayment DateDividend Per Share 
2021March 12, 2021March 31, 2021April 30, 2021$0.075(1)
(1) At March 31, 2021, we had accrued dividends and dividend equivalents payable of $33.6 million related to the common stock dividend declared on March 12, 2021.
Schedule of changes in balances of each component of the entity's AOCI
The following table presents changes in the balances of each component of the Company’s AOCI for the three months ended March 31, 2021:
Three Months Ended
March 31, 2021
(In Thousands)Net Unrealized
Gain/(Loss) on
AFS Securities		Net 
Gain/(Loss)
on Swaps
Net Unrealized Gain/(Loss) on Financing Agreements (3)
Total 
AOCI
Balance at beginning of period$79,607 $— $(2,314)$77,293 
OCI before reclassifications(3,855)— 235 (3,620)
Amounts reclassified from AOCI (1)
— — — — 
Net OCI during the period (2)
(3,855)— 235 (3,620)
Balance at end of period$75,752 $— $(2,079)$73,673 

(1)  See separate table below for details about these reclassifications.
(2)  For further information regarding changes in OCI, see the Company’s consolidated statements of comprehensive income/(loss).
(3) Net Unrealized Gain/(Loss) on Financing Agreements at Fair Value due to changes in instrument-specific credit risk.
 

The following table presents changes in the balances of each component of the Company’s AOCI for the three months ended March 31, 2020:
Three Months Ended
March 31, 2020
(In Thousands)Net Unrealized
Gain/(Loss) on
AFS Securities		Net Gain/(Loss) on SwapsTotal AOCI
Balance at beginning of period$392,722 $(22,675)$370,047 
OCI before reclassifications124,410 (50,127)74,283 
Amounts reclassified from AOCI (1)
(368,222)1,594 (366,628)
Net OCI during the period (2)
(243,812)(48,533)(292,345)
Balance at end of period$148,910 $(71,208)$77,702 

(1)  See separate table below for details about these reclassifications.
(2)  For further information regarding changes in OCI, see the Company’s consolidated statements of comprehensive income/(loss).
Information about the significant amounts reclassified out of the entity's AOCI
The following table presents information about the significant amounts reclassified out of the Company’s AOCI for the three months ended March 31, 2021:
Three Months Ended
March 31, 2021
Details about AOCI ComponentsAmounts Reclassified from AOCIAffected Line Item in the Statement
Where Net Income is Presented
(In Thousands)
AFS Securities:
Realized gain on sale of securities
$— Net realized loss on sales of securities and residential whole loans
Impairment recognized in earnings
— 
Other, net
Total AFS Securities$— 
Total reclassifications for period$— 
 

The following table presents information about the significant amounts reclassified out of the Company’s AOCI for the three months ended March 31, 2020:
Three Months Ended
March 31, 2020
Details about AOCI ComponentsAmounts Reclassified from AOCIAffected Line Item in the Statement
Where Net Income is Presented
(In Thousands)
AFS Securities:
Realized gain on sale of securities$(23,953)Net realized loss on sales of securities and residential whole loans
Impairment recognized in earnings(344,269)Other, net
Total AFS Securities$(368,222)
Swaps designated as cash flow hedges:
Amortization of de-designated hedging instruments1,594 Other, net
Total Swaps designated as cash flow hedges1,594 
Total reclassifications for period$(366,628)